Redmile Group as of June 30, 2023
Portfolio Holdings for Redmile Group
Redmile Group holds 72 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ImmunoGen | 12.8 | $335M | 18M | 18.87 | |
| Krystal Biotech (KRYS) | 11.6 | $301M | 2.6M | 117.40 | |
| Amicus Therapeutics (FOLD) | 9.4 | $246M | 20M | 12.56 | |
| Replimune Group (REPL) | 3.9 | $103M | 4.4M | 23.22 | |
| Akero Therapeutics (AKRO) | 3.2 | $85M | 1.8M | 46.69 | |
| Augmedix (AUGX) | 2.9 | $75M | 16M | 4.81 | |
| Deciphera Pharmaceuticals | 2.6 | $69M | 4.9M | 14.08 | |
| Fate Therapeutics (FATE) | 2.4 | $63M | 13M | 4.76 | |
| Celldex Therapeutics Com New (CLDX) | 2.2 | $58M | 1.7M | 33.93 | |
| Livanova SHS (LIVN) | 2.2 | $57M | 1.1M | 51.43 | |
| Catalent | 1.9 | $50M | 1.2M | 43.36 | |
| Zymeworks Del (ZYME) | 1.9 | $49M | 5.7M | 8.64 | |
| Pliant Therapeutics (PLRX) | 1.9 | $49M | 2.7M | 18.12 | |
| Penumbra (PEN) | 1.8 | $48M | 139k | 344.06 | |
| Beam Therapeutics (BEAM) | 1.8 | $47M | 1.5M | 31.93 | |
| Xenon Pharmaceuticals (XENE) | 1.7 | $43M | 1.1M | 38.50 | |
| Kymera Therapeutics (KYMR) | 1.6 | $43M | 1.9M | 22.99 | |
| BioMarin Pharmaceutical (BMRN) | 1.6 | $42M | 489k | 86.68 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.6 | $42M | 342k | 123.97 | |
| Stoke Therapeutics (STOK) | 1.6 | $42M | 4.0M | 10.63 | |
| Regenxbio Inc equity us cm (RGNX) | 1.6 | $41M | 2.0M | 19.99 | |
| Dex (DXCM) | 1.4 | $37M | 289k | 128.51 | |
| Immunovant (IMVT) | 1.4 | $36M | 1.9M | 18.97 | |
| Anthem (ELV) | 1.3 | $35M | 78k | 444.29 | |
| Scholar Rock Hldg Corp (SRRK) | 1.3 | $33M | 4.4M | 7.54 | |
| Ventyx Biosciences (VTYX) | 1.2 | $31M | 941k | 32.80 | |
| Adc Therapeutics Sa SHS (ADCT) | 1.2 | $30M | 14M | 2.15 | |
| Nurix Therapeutics (NRIX) | 1.1 | $29M | 2.9M | 9.99 | |
| Igm Biosciences (IGMS) | 1.1 | $27M | 3.0M | 9.23 | |
| Stryker Corporation (SYK) | 1.0 | $26M | 86k | 305.09 | |
| Repare Therapeutics Ord (RPTX) | 1.0 | $26M | 2.4M | 10.58 | |
| Cogent Biosciences (COGT) | 0.9 | $24M | 2.1M | 11.84 | |
| Charles River Laboratories (CRL) | 0.9 | $24M | 114k | 210.25 | |
| Zimmer Holdings (ZBH) | 0.8 | $22M | 151k | 145.60 | |
| Iqvia Holdings (IQV) | 0.8 | $21M | 94k | 224.77 | |
| Boston Scientific Corporation (BSX) | 0.8 | $21M | 391k | 54.09 | |
| Humana (HUM) | 0.8 | $21M | 46k | 447.13 | |
| Verve Therapeutics (VERV) | 0.8 | $20M | 1.1M | 18.75 | |
| Entrada Therapeutics (TRDA) | 0.8 | $20M | 1.3M | 15.14 | |
| Prime Medicine (PRME) | 0.7 | $19M | 1.3M | 14.65 | |
| Cabaletta Bio (CABA) | 0.7 | $18M | 1.4M | 12.91 | |
| Shattuck Labs (STTK) | 0.7 | $18M | 5.6M | 3.12 | |
| 89bio (ETNB) | 0.6 | $14M | 762k | 18.95 | |
| Gritstone Oncology Ord (GRTSQ) | 0.5 | $13M | 6.9M | 1.95 | |
| Annexon (ANNX) | 0.5 | $12M | 3.5M | 3.52 | |
| Absci Corp (ABSI) | 0.5 | $12M | 8.0M | 1.52 | |
| Allakos | 0.4 | $10M | 2.3M | 4.36 | |
| Stereotaxis Com New (STXS) | 0.4 | $9.8M | 6.4M | 1.53 | |
| Atara Biotherapeutics | 0.4 | $9.7M | 6.0M | 1.61 | |
| Alx Oncology Hldgs (ALXO) | 0.4 | $9.6M | 1.3M | 7.51 | |
| Medavail Holdings Ord | 0.3 | $8.5M | 35M | 0.25 | |
| Rapt Therapeutics | 0.3 | $8.1M | 432k | 18.70 | |
| Acelyrin | 0.3 | $7.6M | 365k | 20.90 | |
| Stevanato Group S P A Ord Shs (STVN) | 0.3 | $7.1M | 218k | 32.38 | |
| Allovir (ALVR) | 0.2 | $6.5M | 1.9M | 3.40 | |
| Evolent Health Cl A (EVH) | 0.2 | $6.5M | 213k | 30.30 | |
| Mersana Therapeutics | 0.2 | $5.6M | 1.7M | 3.29 | |
| Grifols S A Sp Adr Rep B Nvt (GRFS) | 0.2 | $5.5M | 601k | 9.16 | |
| Nuvation Bio Com Cl A (NUVB) | 0.2 | $5.5M | 3.0M | 1.80 | |
| Somalogic Class A Com | 0.2 | $4.3M | 1.9M | 2.31 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.2 | $4.2M | 2.1M | 2.03 | |
| Science 37 Holdings | 0.2 | $4.2M | 20M | 0.21 | |
| Hookipa Pharma Inc equity | 0.1 | $2.9M | 3.3M | 0.88 | |
| Xeris Pharmaceuticals (XERS) | 0.1 | $2.7M | 1.0M | 2.62 | |
| Invitae (NVTAQ) | 0.1 | $2.6M | 2.3M | 1.13 | |
| Neoleukin Therapeutics | 0.1 | $2.4M | 2.9M | 0.83 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $1.5M | 1.6M | 0.95 | |
| Adagio Therapeutics (IVVD) | 0.1 | $1.5M | 1.4M | 1.05 | |
| Alpha Teknova (TKNO) | 0.0 | $825k | 309k | 2.67 | |
| Sonendo (SONX) | 0.0 | $678k | 498k | 1.36 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.0 | $662k | 716k | 0.93 | |
| Atreca Cl A Com (BCEL) | 0.0 | $434k | 443k | 0.98 |